文献速递甲状腺疾病

先天性甲状腺功能减退伴甲状腺发育不良与TPO突变

Thyroid Hypoplasia in Congenital Hypothyroidism Associated with Thyroid Peroxidase Mutations.
PubMed 文献 · Thyroid · 2018-01-01

该研究报告了两个家系中先天性甲状腺功能减退(CH)伴甲状腺发育不良(TD)的患儿,经全外显子测序意外发现三个不同的甲状腺过氧化物酶(TPO)基因变异:突尼斯患儿为纯合错义突变(c.875C>T, p.S292F),法国两同胞为复合杂合突变(c.387delC/c.2578G>A, p.N129Kfs*80/p.G860R)。这是首次报道新生儿期诊断的CH伴TPO突变患者出现甲状腺发育不良,提示TPO突变筛查不应仅限于甲状腺肿型CH,也应考虑正常或小体积甲状腺的CH。

要点

  • 首次报道新生儿期CH伴TPO突变者出现甲状腺发育不良。
  • 三个TPO变异此前均在甲状腺肿型CH患者中描述过。
  • TPO突变筛查范围应扩展至正常或小体积甲状腺的CH。

核心结论

  • 首次报道新生儿期诊断的CH伴TPO突变患者出现甲状腺发育不良,拓宽了TPO突变相关表型谱。

研究设计与样本

  • 采用全外显子测序研究两个家系:一个突尼斯近亲家系(一名严重甲状腺发育不良患儿)和一个法国家系(两名新生儿同胞,诊断时超声示甲状腺原位且未增大)。

主要发现

  • 突尼斯患儿检出TPO纯合错义突变c.875C>T(p.S292F)。
  • 法国两同胞检出TPO复合杂合突变c.387delC/c.2578G>A(p.N129Kfs*80/p.G860R)。
  • 三个TPO变异此前均在甲状腺肿型CH患者中报道过。
  • 所有患者确诊后立即开始治疗,促甲状腺激素对甲状腺的刺激效应尚不明确。

临床怎么用

  • 对CH患者应筛查TPO突变,不仅限于甲状腺肿型,也包括甲状腺正常或小体积者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary congenital hypothyroidism (CH) affects about 1:3000 newborns worldwide and is mainly caused by defects in thyroid gland development (thyroid dysgenesis [TD]) or hormone synthesis. A genetic cause is identified in <10% of TD patients. The aim was to identify novel candidate genes in patients with TD using next-generation sequencing tools. PATIENT FINDINGS: Whole exome sequencing was used to study two families: a consanguineous Tunisian family (one child with severe thyroid hypoplasia) and a French family (two newborn siblings, with a thyroid in situ that was not enlarged on ultrasound at diagnosis). Variants in candidate genes were filtered according to type of variation, frequency in public and in-house databases, in silico prediction tools, and inheritance mode. Unexpectedly, three different variants of the thyroid peroxidase (TPO) gene were identified. A homozygous missense mutation (c.875C>T, p.S292F) was found in the Tunisian patient with severe thyroid hypoplasia. The two French siblings were compound heterozygotes (c.387delC/c.2578G>A, p.N129Kfs*80/p.G860R) for TPO mutations. All three mutations have been previously described in patients with goitrous CH. In these patients, treatment was initiated immediately after diagnosis, and the effect, if any, of thyrotropin stimulation of these thyroids remains unclear. CONCLUSIONS: The first cases are reported of thyroid hypoplasia at diagnosis during the neonatal period in patients with CH and TPO mutations. These cases highlight the importance of screening for TPO mutations not only in goitrous CH, but also in normal or small-size thyroids, and they broaden the clinical spectrum of described phenotypes.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Stoupa A, Chaabane R, Guériouz M, et al. Thyroid Hypoplasia in Congenital Hypothyroidism Associated with Thyroid Peroxidase Mutations. Thyroid. 2018. PMID: 29790453. doi:10.1089/thy.2017.0502

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。